NYXH
Nyxoah
NASDAQ: NYXH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$2.95
+0.68% today
Updated 2026-04-30
Market cap
$130.99M
P/E ratio
—
P/S ratio
13.07x
EPS (TTM)
$-2.77
Dividend yield
—
52W range
$3 – $9
Volume
0.1M
Nyxoah (NYXH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.29M | $-8.14M | $-5.93M | $-6.86M | $-25.34M | $-28.76M | $-44.78M | $-49.23M | $-67.50M |
| Capital expenditures | $91000.00 | $77000.00 | $5.79M | $10.68M | $11.82M | $16.35M | $10.96M | $6.07M | $804698.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $24000.00 | $28000.00 | $346000.00 | $2.55M | $1.27M | $2.70M | $2.61M | $3.97M | $4.89M |
| Free cash flow | $-8.38M | $-8.22M | $-11.72M | $-17.54M | $-37.15M | $-45.10M | $-55.74M | $-55.30M | $-68.30M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |